Image - 5 April 2022

Magnus Essand

Magnus Essand, Professor at the Department of Immunology, Genetics and Pathology, Uppsala University

License:: Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
By:: David Naylor
File format:: .jpg
Size:: 1600 x 1067, 258 KB

Download

Contacts

Elin Bäckström

Press contact Press Officer Research Education elin.backstrom@uu.se +46-70-425 09 83

Linda Koffmar

Press contact Press Officer linda.koffmar@uu.se +46 (0)18-471 19 59

Sandra Gunnarsson

Press contact Press Officer sandra.gunnarsson@uu.se +4673 469 75 92

Armed CAR-T cells to better fight cancer

Immunotherapy is increasingly becoming a successful way to treat cancer. Researchers at Uppsala University have now developed armed CAR-T cells that reinforce the immune defence against cancer and that could increase the possibilities to successfully treat solid tumours. The study has been published in the journal Nature BioMedical Engineering.

Uppsala University - quality, knowledge, and creativity since 1477

Founded in 1477, Uppsala University is the oldest university in Sweden. With more than 50,000 students and 7,500 employees in Uppsala and Visby, we are a broad university with research in social sciences, humanities, technology, natural sciences, medicine and pharmacology. Our mission is to conduct education and research of the highest quality and relevance to society on a long-term basis. Uppsala University is regularly ranked among the world’s top universities.